References
- Byne, W., Bradley, S. J., Coleman, E., Eyler, A. E., Green, R., Menvielle, E. J., … American Psychiatric Association Task Force on Treatment of Gender Identity, D. (2012). Report of the American Psychiatric Association task force on treatment of gender identity disorder. Archives of Sexual Behavior, 41(4), 759–796. doi:10.1007/s10508-012-9975-x
- Caanen, M. R., Soleman, R. S., Kuijper, E. A., Kreukels, B. P., De Roo, C., Tilleman, K., … Lambalk, C. B. (2015). Antimullerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy. Fertility and Sterility, 103(5), 1340–1345. doi:10.1016/j.fertnstert.2015.02.003
- Chen, D., Simons, L., Johnson, E. K., Lockart, B. A., & Finlayson, C. (2017). Fertility preservation for transgender adolescents. Journal of Adolescent Health, 61(1), 120–123. doi.org/10.1016/j.jadohealth.2017.01.022
- Committee on Adolescent Health. (2017). Committee opinion No. 685: Care for transgender adolescents. Obstetrics & Gynecology, 129(1), e11–e16. doi:10.1097/AOG.0000000000001861
- Deutsch, M. B., & Feldman, J. L. (2013). Updated recommendations from the World Professional Association for Transgender Health standards of care. American Family Physician, 87(2), 89–93.
- Ethics Committee of the American Society of Reproductive Medicine. (2015). Access to fertility services by transgender persons: An ethics committee opinion. Fertility and Sterility, 104(5), 1111–1115. doi:10.1016/j.fertnstert.2015.08.021
- Feldman, J., Brown, G. R., Deutsch, M. B., Hembree, W., Meyer, W., Meyer-Bahlburg, H. F., … Safer, J. D. (2016). Priorities for transgender medical and healthcare research. Current Opinion in Endocrinology, Diabetes and Obesity, 23(2), 180–187. doi:10.1097/MED.0000000000000231
- Hakim, C., Padmanabhan, V., & Vyas, A. K. (2017). Gestational hyperandrogenism in developmental programming. Endocrinology, 158(2), 199–212. doi:10.1210/en.2016-1801
- Hembree, W. C., Cohen-Kettenis, P., Delemarre-van de Waal, H. A., Gooren, L. J., Meyer, W. J., III, & Spack, N. P. (2009). Endocrine treatment of transsexual persons: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 94(9), 3132–3154. doi:10.1210/jc.2009-0345
- Ikeda, K., Baba, T., Noguchi, H., Nagasawa, K., Endo, T., Kiya, T., & Saito, T. (2013). Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology. Human Reproduction, 28(2), 453–461. doi:10.1093/humrep/des385
- Nahata, L., Tishelman, A. C., Caltabellotta, N. M., & Quinn, G. P. (2017). Low fertility preservation utilization among transgender youth. Journal of Adolescent Health 61(1), 40–44. doi:10.1016/j.jadohealth.2016.12.012
- Van Den Broecke, R., Van Der Elst, J., Liu, J., Hovatta, O., & Dhont, M. (2001). The female-to-male transsexual patient: A source of human ovarian cortical tissue for experimental use. Human Reproduction, 16(1), 145–147.
- Wallace, S. A., Blough, K. L., & Kondapalli, L. A. (2014). Fertility preservation in the transgender patient: Expanding oncofertility care beyond cancer. Gynecological Endocrinology, 30(12), 868–871. doi:10.3109/09513590.2014.920005